

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.31999775 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.13891991 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.13891991 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.13891991 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.13891991 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.13891991 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.13891991 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 6.01178031 |
| 9 | respiratory burst (GO:0045730) | 4.85971927 |
| 10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.65829583 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 4.61770377 |
| 12 | macrophage activation involved in immune response (GO:0002281) | 4.59999552 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 4.54043871 |
| 14 | glycosphingolipid catabolic process (GO:0046479) | 4.52280293 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 4.36157862 |
| 16 | response to peptidoglycan (GO:0032494) | 4.26787896 |
| 17 | granulocyte activation (GO:0036230) | 4.26740546 |
| 18 | glycolipid catabolic process (GO:0019377) | 4.17703961 |
| 19 | oligosaccharide catabolic process (GO:0009313) | 4.07413873 |
| 20 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.06607215 |
| 21 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.05856943 |
| 22 | angiotensin maturation (GO:0002003) | 4.05054343 |
| 23 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.04925936 |
| 24 | response to host immune response (GO:0052572) | 4.04925936 |
| 25 | neutrophil activation (GO:0042119) | 3.99509211 |
| 26 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.90685692 |
| 27 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.86792286 |
| 28 | natural killer cell mediated immunity (GO:0002228) | 3.85427627 |
| 29 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.85427627 |
| 30 | superoxide anion generation (GO:0042554) | 3.82023009 |
| 31 | myeloid cell activation involved in immune response (GO:0002275) | 3.77494908 |
| 32 | positive regulation of antigen processing and presentation (GO:0002579) | 3.75019117 |
| 33 | positive regulation of mast cell activation (GO:0033005) | 3.72836191 |
| 34 | regulation of vitamin metabolic process (GO:0030656) | 3.72576026 |
| 35 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.71234128 |
| 36 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.66308098 |
| 37 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.65712217 |
| 38 | regulation of cholesterol storage (GO:0010885) | 3.60487395 |
| 39 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.58088884 |
| 40 | response to host defenses (GO:0052200) | 3.57973289 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.57973289 |
| 42 | response to host (GO:0075136) | 3.57973289 |
| 43 | adhesion of symbiont to host cell (GO:0044650) | 3.56400681 |
| 44 | virion attachment to host cell (GO:0019062) | 3.56400681 |
| 45 | barbed-end actin filament capping (GO:0051016) | 3.56016662 |
| 46 | ceramide catabolic process (GO:0046514) | 3.55467077 |
| 47 | reactive oxygen species biosynthetic process (GO:1903409) | 3.54378632 |
| 48 | low-density lipoprotein particle clearance (GO:0034383) | 3.49769510 |
| 49 | wound healing, spreading of epidermal cells (GO:0035313) | 3.48078310 |
| 50 | positive regulation of mast cell degranulation (GO:0043306) | 3.39490323 |
| 51 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.39490323 |
| 52 | phagosome maturation (GO:0090382) | 3.34100912 |
| 53 | B cell mediated immunity (GO:0019724) | 3.32896730 |
| 54 | response to muramyl dipeptide (GO:0032495) | 3.29822364 |
| 55 | regulation of mast cell degranulation (GO:0043304) | 3.29405358 |
| 56 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.29134017 |
| 57 | positive regulation of interferon-beta production (GO:0032728) | 3.28783480 |
| 58 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.28073980 |
| 59 | microglial cell activation (GO:0001774) | 3.26248730 |
| 60 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.26179698 |
| 61 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.25585455 |
| 62 | macrophage activation (GO:0042116) | 3.24874712 |
| 63 | regulation of antigen processing and presentation (GO:0002577) | 3.24222745 |
| 64 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.21070497 |
| 65 | positive regulation of leukocyte degranulation (GO:0043302) | 3.19643328 |
| 66 | lymphocyte chemotaxis (GO:0048247) | 3.17804006 |
| 67 | membrane lipid catabolic process (GO:0046466) | 3.16094415 |
| 68 | pinocytosis (GO:0006907) | 3.12430003 |
| 69 | regulation of mast cell activation (GO:0033003) | 3.12300872 |
| 70 | myeloid dendritic cell differentiation (GO:0043011) | 3.12112788 |
| 71 | adhesion of symbiont to host (GO:0044406) | 3.11779498 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.08422498 |
| 73 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.07788857 |
| 74 | sphingolipid catabolic process (GO:0030149) | 3.06697416 |
| 75 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.05390101 |
| 76 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.05145044 |
| 77 | phagocytosis, recognition (GO:0006910) | 3.04896932 |
| 78 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.04789319 |
| 79 | peptide catabolic process (GO:0043171) | 3.04747782 |
| 80 | defense response to protozoan (GO:0042832) | 3.03260043 |
| 81 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.02458712 |
| 82 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.99462573 |
| 83 | myeloid dendritic cell activation (GO:0001773) | 2.97430289 |
| 84 | cellular extravasation (GO:0045123) | 2.95963937 |
| 85 | actin nucleation (GO:0045010) | 2.94221917 |
| 86 | regulation of leukocyte degranulation (GO:0043300) | 2.94179299 |
| 87 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.93994486 |
| 88 | cellular response to type I interferon (GO:0071357) | 2.91940055 |
| 89 | type I interferon signaling pathway (GO:0060337) | 2.91940055 |
| 90 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.91514530 |
| 91 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.91285232 |
| 92 | negative regulation of mast cell activation (GO:0033004) | 2.90497522 |
| 93 | response to type I interferon (GO:0034340) | 2.90262755 |
| 94 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.89422407 |
| 95 | leukocyte mediated cytotoxicity (GO:0001909) | 2.88795964 |
| 96 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.88116839 |
| 97 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.88116839 |
| 98 | myeloid leukocyte activation (GO:0002274) | 2.87943343 |
| 99 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.87166468 |
| 100 | Golgi transport vesicle coating (GO:0048200) | 2.84140750 |
| 101 | COPI coating of Golgi vesicle (GO:0048205) | 2.84140750 |
| 102 | regulation of podosome assembly (GO:0071801) | 2.82988917 |
| 103 | regulation of chemokine biosynthetic process (GO:0045073) | 2.82314813 |
| 104 | myeloid cell homeostasis (GO:0002262) | 2.81882238 |
| 105 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.81473316 |
| 106 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.81325225 |
| 107 | amino sugar catabolic process (GO:0046348) | 2.80392735 |
| 108 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.78792042 |
| 109 | cellular response to interferon-alpha (GO:0035457) | 2.77737615 |
| 110 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.76749212 |
| 111 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.76733545 |
| 112 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.76692198 |
| 113 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.76391280 |
| 114 | positive regulation of macrophage cytokine production (GO:0060907) | 2.75504081 |
| 115 | cellular response to zinc ion (GO:0071294) | 2.74670536 |
| 116 | T-helper 1 type immune response (GO:0042088) | 2.74402155 |
| 117 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.74394792 |
| 118 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.74306791 |
| 119 | regulation of monocyte chemotaxis (GO:0090025) | 2.74061513 |
| 120 | lymphocyte mediated immunity (GO:0002449) | 2.73714651 |
| 121 | leukocyte aggregation (GO:0070486) | 2.73565009 |
| 122 | positive regulation of interleukin-6 production (GO:0032755) | 2.71857469 |
| 123 | detection of molecule of bacterial origin (GO:0032490) | 2.70663450 |
| 124 | dendritic cell differentiation (GO:0097028) | 2.70288084 |
| 125 | negative regulation of interleukin-17 production (GO:0032700) | 2.68859103 |
| 126 | response to thyroid hormone (GO:0097066) | 2.67325596 |
| 127 | protein localization to endosome (GO:0036010) | 2.66501786 |
| 128 | transcytosis (GO:0045056) | 2.60400616 |
| 129 | phospholipid efflux (GO:0033700) | 2.56185871 |
| 130 | regulation of cellular extravasation (GO:0002691) | 2.53482219 |
| 131 | negative regulation of interleukin-12 production (GO:0032695) | 2.51649879 |
| 132 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.51100117 |
| 133 | regulation of cholesterol esterification (GO:0010872) | 2.50537682 |
| 134 | cyclooxygenase pathway (GO:0019371) | 2.50522023 |
| 135 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48970229 |
| 136 | lipoprotein transport (GO:0042953) | 2.48788069 |
| 137 | keratan sulfate catabolic process (GO:0042340) | 2.48573996 |
| 138 | apoptotic cell clearance (GO:0043277) | 2.47691879 |
| 139 | * regulation of mononuclear cell migration (GO:0071675) | 2.47141318 |
| 140 | positive regulation of pseudopodium assembly (GO:0031274) | 2.44971663 |
| 141 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.44559264 |
| 142 | NIK/NF-kappaB signaling (GO:0038061) | 2.42678126 |
| 143 | positive regulation of extracellular matrix organization (GO:1903055) | 2.41361694 |
| 144 | protein-lipid complex assembly (GO:0065005) | 2.37756908 |
| 145 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.37375874 |
| 146 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.37375874 |
| 147 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.35870095 |
| 148 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.34128119 |
| 149 | detection of other organism (GO:0098543) | 2.32595119 |
| 150 | regulation of macrophage chemotaxis (GO:0010758) | 2.32157208 |
| 151 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.31923441 |
| 152 | plasma lipoprotein particle assembly (GO:0034377) | 2.29969201 |
| 153 | NADH metabolic process (GO:0006734) | 2.29522787 |
| 154 | intestinal absorption (GO:0050892) | 2.28777990 |
| 155 | regulation of superoxide anion generation (GO:0032928) | 2.26260490 |
| 156 | desmosome organization (GO:0002934) | 2.25785827 |
| 157 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.25773603 |
| 158 | amyloid precursor protein catabolic process (GO:0042987) | 2.25357066 |
| 159 | bone resorption (GO:0045453) | 2.23179920 |
| 160 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.22222203 |
| 161 | detection of bacterium (GO:0016045) | 2.19136739 |
| 162 | regulation of metalloenzyme activity (GO:0048552) | 2.18790798 |
| 163 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.18520928 |
| 164 | regulation of cholesterol homeostasis (GO:2000188) | 2.18228544 |
| 165 | epoxygenase P450 pathway (GO:0019373) | 2.17031904 |
| 166 | fibril organization (GO:0097435) | 2.16886791 |
| 167 | fructose metabolic process (GO:0006000) | 2.16020101 |
| 168 | ethanol oxidation (GO:0006069) | 2.15066843 |
| 169 | regulation of pseudopodium assembly (GO:0031272) | 2.13191542 |
| 170 | * eosinophil chemotaxis (GO:0048245) | 2.11505721 |
| 171 | regulation of extracellular matrix disassembly (GO:0010715) | 2.11361126 |
| 172 | interferon-gamma secretion (GO:0072643) | 2.10122672 |
| 173 | ethanol metabolic process (GO:0006067) | 2.09013990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.72292310 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.17429028 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.98195214 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.28583250 |
| 5 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.16687854 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.03366471 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.71236659 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.55494759 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.14700751 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.05930782 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.04833702 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.95417744 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.93588960 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.85722872 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.60954825 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.46711541 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43988546 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40459212 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.33432783 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29124470 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.28463119 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.28123697 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23030301 |
| 24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22727628 |
| 25 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.12428247 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.04306009 |
| 27 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.03159525 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.01952845 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.95671351 |
| 30 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.94586439 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89086630 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.84126771 |
| 33 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.76081625 |
| 34 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73412403 |
| 35 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.72894818 |
| 36 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.71091058 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.71031405 |
| 38 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.68359751 |
| 39 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.68222399 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65480851 |
| 41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63936283 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63365228 |
| 43 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63198929 |
| 44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.61186935 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.59800969 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59424125 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.59268951 |
| 48 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54785407 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54152703 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51232839 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50261052 |
| 52 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43364399 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42035827 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.41878303 |
| 55 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41363431 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40531726 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40397021 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.36995276 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36670460 |
| 60 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34672742 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34478805 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.34096847 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33228457 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.31745746 |
| 65 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.31324247 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.31150117 |
| 67 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30762488 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26287830 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23465757 |
| 70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.22464442 |
| 71 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22206674 |
| 72 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20997837 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20516749 |
| 74 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19225801 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19152982 |
| 76 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18432243 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17680629 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17680629 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16347844 |
| 80 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.15099730 |
| 81 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.15099730 |
| 82 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.14115388 |
| 83 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14059242 |
| 84 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12548824 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12480881 |
| 86 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12253844 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11534494 |
| 88 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.09447387 |
| 89 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09103583 |
| 90 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.08883352 |
| 91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.06137562 |
| 92 | MYB_26560356_Chip-Seq_TH1_Human | 1.05953159 |
| 93 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05483616 |
| 94 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04484684 |
| 95 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04100291 |
| 96 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03673184 |
| 97 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.01471166 |
| 98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01162415 |
| 99 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00022003 |
| 100 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99278640 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98814021 |
| 102 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98156232 |
| 103 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98074841 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96735396 |
| 105 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96505692 |
| 106 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.95943741 |
| 107 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94704497 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94104193 |
| 109 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94062874 |
| 110 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93578554 |
| 111 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93500021 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93155970 |
| 113 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.92225386 |
| 114 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.92166996 |
| 115 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.91953103 |
| 116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91313204 |
| 117 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.91069916 |
| 118 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91014084 |
| 119 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90555420 |
| 120 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.88357361 |
| 121 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.88344363 |
| 122 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.87874830 |
| 123 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87854790 |
| 124 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87749443 |
| 125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87345469 |
| 126 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86662364 |
| 127 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85893306 |
| 128 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84981168 |
| 129 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84254745 |
| 130 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82321113 |
| 131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81776772 |
| 132 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80635470 |
| 133 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79796503 |
| 134 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77389786 |
| 135 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76598489 |
| 136 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.75343014 |
| 137 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74807201 |
| 138 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.73900538 |
| 139 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.72786687 |
| 140 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71719603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.15973884 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.06262572 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.81836150 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.41804260 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.32412442 |
| 6 | MP0009785_altered_susceptibility_to | 3.29754354 |
| 7 | * MP0002419_abnormal_innate_immunity | 3.09278791 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.97415364 |
| 9 | * MP0005025_abnormal_response_to | 2.72612097 |
| 10 | * MP0006082_CNS_inflammation | 2.65145301 |
| 11 | MP0001790_abnormal_immune_system | 2.46508427 |
| 12 | MP0005387_immune_system_phenotype | 2.46508427 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.45399636 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.32738938 |
| 15 | MP0004510_myositis | 2.32671711 |
| 16 | MP0000685_abnormal_immune_system | 2.24913270 |
| 17 | * MP0003303_peritoneal_inflammation | 2.24045263 |
| 18 | MP0001533_abnormal_skeleton_physiology | 2.23625530 |
| 19 | MP0003724_increased_susceptibility_to | 2.20170853 |
| 20 | MP0002723_abnormal_immune_serum | 2.19748675 |
| 21 | MP0005257_abnormal_intraocular_pressure | 2.16494918 |
| 22 | MP0005671_abnormal_response_to | 2.10835895 |
| 23 | MP0004947_skin_inflammation | 2.05340639 |
| 24 | MP0003448_altered_tumor_morphology | 2.04105157 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.02523178 |
| 26 | * MP0001800_abnormal_humoral_immune | 2.02168900 |
| 27 | MP0005360_urolithiasis | 2.01067271 |
| 28 | * MP0001819_abnormal_immune_cell | 1.99232518 |
| 29 | * MP0002420_abnormal_adaptive_immunity | 1.95295975 |
| 30 | MP0000343_altered_response_to | 1.92020928 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.91172876 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.89190475 |
| 33 | MP0005365_abnormal_bile_salt | 1.82659067 |
| 34 | MP0009840_abnormal_foam_cell | 1.81941366 |
| 35 | MP0005451_abnormal_body_composition | 1.79137231 |
| 36 | * MP0001845_abnormal_inflammatory_respons | 1.74539109 |
| 37 | * MP0002405_respiratory_system_inflammati | 1.73360324 |
| 38 | MP0004019_abnormal_vitamin_homeostasis | 1.72572468 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.71453402 |
| 40 | MP0000604_amyloidosis | 1.69445307 |
| 41 | MP0001853_heart_inflammation | 1.67535774 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.65199483 |
| 43 | MP0005310_abnormal_salivary_gland | 1.64313320 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.63048398 |
| 45 | MP0009764_decreased_sensitivity_to | 1.62815948 |
| 46 | MP0002877_abnormal_melanocyte_morpholog | 1.62671289 |
| 47 | MP0003690_abnormal_glial_cell | 1.58790231 |
| 48 | MP0000858_altered_metastatic_potential | 1.57573501 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.55392892 |
| 50 | MP0003075_altered_response_to | 1.54929680 |
| 51 | * MP0010155_abnormal_intestine_physiology | 1.54069229 |
| 52 | MP0008469_abnormal_protein_level | 1.52161700 |
| 53 | MP0003329_amyloid_beta_deposits | 1.50135738 |
| 54 | MP0004264_abnormal_extraembryonic_tissu | 1.49991952 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.49542795 |
| 56 | MP0009333_abnormal_splenocyte_physiolog | 1.47528179 |
| 57 | MP0010307_abnormal_tumor_latency | 1.45740029 |
| 58 | MP0000566_synostosis | 1.38510952 |
| 59 | MP0005085_abnormal_gallbladder_physiolo | 1.37793147 |
| 60 | MP0008438_abnormal_cutaneous_collagen | 1.34928522 |
| 61 | MP0001851_eye_inflammation | 1.33836978 |
| 62 | * MP0000716_abnormal_immune_system | 1.29640796 |
| 63 | MP0001664_abnormal_digestion | 1.29363820 |
| 64 | MP0002796_impaired_skin_barrier | 1.28274281 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.26375800 |
| 66 | MP0005167_abnormal_blood-brain_barrier | 1.26163650 |
| 67 | MP0005165_increased_susceptibility_to | 1.26067196 |
| 68 | MP0001666_abnormal_nutrient_absorption | 1.24442682 |
| 69 | MP0010386_abnormal_urinary_bladder | 1.21185876 |
| 70 | * MP0005166_decreased_susceptibility_to | 1.20312452 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 1.17371145 |
| 72 | MP0008260_abnormal_autophagy | 1.17340840 |
| 73 | MP0005390_skeleton_phenotype | 1.16991440 |
| 74 | MP0008004_abnormal_stomach_pH | 1.16404160 |
| 75 | MP0002254_reproductive_system_inflammat | 1.15977383 |
| 76 | MP0002006_tumorigenesis | 1.14984245 |
| 77 | MP0002933_joint_inflammation | 1.14722873 |
| 78 | MP0010234_abnormal_vibrissa_follicle | 1.14156711 |
| 79 | MP0005076_abnormal_cell_differentiation | 1.13323892 |
| 80 | MP0006054_spinal_hemorrhage | 1.12686492 |
| 81 | MP0005164_abnormal_response_to | 1.11021890 |
| 82 | * MP0002398_abnormal_bone_marrow | 1.10813848 |
| 83 | MP0009278_abnormal_bone_marrow | 1.10713249 |
| 84 | MP0005174_abnormal_tail_pigmentation | 1.07012352 |
| 85 | MP0003186_abnormal_redox_activity | 1.06936470 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 1.06153602 |
| 87 | MP0001545_abnormal_hematopoietic_system | 1.06153602 |
| 88 | MP0001958_emphysema | 1.05888378 |
| 89 | MP0003828_pulmonary_edema | 1.05289389 |
| 90 | MP0010678_abnormal_skin_adnexa | 1.04527466 |
| 91 | MP0000689_abnormal_spleen_morphology | 1.03958531 |
| 92 | * MP0002429_abnormal_blood_cell | 1.03397540 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 1.02441119 |
| 94 | * MP0005381_digestive/alimentary_phenotyp | 1.00490883 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.99722211 |
| 96 | MP0000490_abnormal_crypts_of | 0.99493263 |
| 97 | MP0005409_darkened_coat_color | 0.98459675 |
| 98 | MP0002722_abnormal_immune_system | 0.95274550 |
| 99 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94700286 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.93597908 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.92172686 |
| 102 | MP0001849_ear_inflammation | 0.90557750 |
| 103 | MP0003795_abnormal_bone_structure | 0.89223746 |
| 104 | MP0003091_abnormal_cell_migration | 0.88020155 |
| 105 | MP0005501_abnormal_skin_physiology | 0.87876281 |
| 106 | MP0004043_abnormal_pH_regulation | 0.87200529 |
| 107 | MP0003866_abnormal_defecation | 0.86652928 |
| 108 | MP0005670_abnormal_white_adipose | 0.86363876 |
| 109 | MP0002166_altered_tumor_susceptibility | 0.86357251 |
| 110 | MP0002277_abnormal_respiratory_mucosa | 0.86092651 |
| 111 | MP0002896_abnormal_bone_mineralization | 0.83597681 |
| 112 | MP0002090_abnormal_vision | 0.83350592 |
| 113 | MP0005023_abnormal_wound_healing | 0.81650251 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.79725272 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.78453367 |
| 116 | MP0005275_abnormal_skin_tensile | 0.77299508 |
| 117 | MP0001542_abnormal_bone_strength | 0.76619367 |
| 118 | MP0000249_abnormal_blood_vessel | 0.76112651 |
| 119 | MP0000465_gastrointestinal_hemorrhage | 0.76040105 |
| 120 | * MP0009763_increased_sensitivity_to | 0.75191999 |
| 121 | MP0000371_diluted_coat_color | 0.69764459 |
| 122 | MP0001873_stomach_inflammation | 0.69182731 |
| 123 | MP0001216_abnormal_epidermal_layer | 0.68285515 |
| 124 | * MP0002136_abnormal_kidney_physiology | 0.66899384 |
| 125 | * MP0001663_abnormal_digestive_system | 0.66388284 |
| 126 | MP0004185_abnormal_adipocyte_glucose | 0.66299146 |
| 127 | MP0003279_aneurysm | 0.63962621 |
| 128 | MP0000015_abnormal_ear_pigmentation | 0.62229526 |
| 129 | MP0004883_abnormal_blood_vessel | 0.60374518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.04570865 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.82102056 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.13353620 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.01556832 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 5.83787072 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 5.71985974 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.46942407 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.92219130 |
| 9 | Axonal loss (HP:0003447) | 4.29028704 |
| 10 | Disinhibition (HP:0000734) | 4.22845776 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.22805188 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.22805188 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.22805188 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 4.13453150 |
| 15 | Gingivitis (HP:0000230) | 3.94882384 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.89960244 |
| 17 | Obstructive lung disease (HP:0006536) | 3.87642768 |
| 18 | Chronic obstructive pulmonary disease (HP:0006510) | 3.87642768 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 3.83829728 |
| 20 | Malnutrition (HP:0004395) | 3.69908836 |
| 21 | Recurrent skin infections (HP:0001581) | 3.66521891 |
| 22 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.61416914 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 3.56589216 |
| 24 | Stomatitis (HP:0010280) | 3.43090563 |
| 25 | Recurrent fungal infections (HP:0002841) | 3.36943532 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.34127797 |
| 27 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.33960682 |
| 28 | Mucopolysacchariduria (HP:0008155) | 3.33960682 |
| 29 | Myositis (HP:0100614) | 3.21103538 |
| 30 | Hyperactive renin-angiotensin system (HP:0000841) | 3.15174880 |
| 31 | Abnormality of the nasal mucosa (HP:0000433) | 3.11188101 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.09205129 |
| 33 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.09205129 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.09205129 |
| 35 | Myocardial infarction (HP:0001658) | 3.08015727 |
| 36 | Loss of speech (HP:0002371) | 3.05914905 |
| 37 | Orchitis (HP:0100796) | 3.05795407 |
| 38 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.00374856 |
| 39 | Amyloidosis (HP:0011034) | 3.00031426 |
| 40 | Basal ganglia calcification (HP:0002135) | 2.99986775 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 2.98688924 |
| 42 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.93786783 |
| 43 | Cellulitis (HP:0100658) | 2.85950420 |
| 44 | Urticaria (HP:0001025) | 2.84506139 |
| 45 | Prostate neoplasm (HP:0100787) | 2.83044529 |
| 46 | Nasal polyposis (HP:0100582) | 2.79372411 |
| 47 | Fat malabsorption (HP:0002630) | 2.76017305 |
| 48 | Neurofibrillary tangles (HP:0002185) | 2.74354349 |
| 49 | Agnosia (HP:0010524) | 2.73603443 |
| 50 | Hepatosplenomegaly (HP:0001433) | 2.71249866 |
| 51 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.70142868 |
| 52 | Pustule (HP:0200039) | 2.66213283 |
| 53 | Thick nail (HP:0001805) | 2.65806303 |
| 54 | Steatorrhea (HP:0002570) | 2.65121828 |
| 55 | Purpura (HP:0000979) | 2.57376168 |
| 56 | Periodontitis (HP:0000704) | 2.54767422 |
| 57 | Optic neuritis (HP:0100653) | 2.53740015 |
| 58 | Retrobulbar optic neuritis (HP:0100654) | 2.53740015 |
| 59 | Vasculitis (HP:0002633) | 2.53320884 |
| 60 | Nuclear cataract (HP:0100018) | 2.52351158 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.45679459 |
| 62 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.45679459 |
| 63 | Xanthomatosis (HP:0000991) | 2.42100559 |
| 64 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.41639002 |
| 65 | Osteomyelitis (HP:0002754) | 2.40455167 |
| 66 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.38095249 |
| 67 | Recurrent pneumonia (HP:0006532) | 2.36815235 |
| 68 | Glomerulonephritis (HP:0000099) | 2.34739633 |
| 69 | Abnormality of complement system (HP:0005339) | 2.31679986 |
| 70 | Recurrent viral infections (HP:0004429) | 2.30683199 |
| 71 | Diminished motivation (HP:0000745) | 2.30424052 |
| 72 | Petechiae (HP:0000967) | 2.30308561 |
| 73 | Vertebral compression fractures (HP:0002953) | 2.29982813 |
| 74 | Abnormality of proline metabolism (HP:0010907) | 2.28704855 |
| 75 | Hydroxyprolinuria (HP:0003080) | 2.28704855 |
| 76 | Complement deficiency (HP:0004431) | 2.27256835 |
| 77 | Pathologic fracture (HP:0002756) | 2.25040834 |
| 78 | Flat acetabular roof (HP:0003180) | 2.21955094 |
| 79 | Bone pain (HP:0002653) | 2.21544152 |
| 80 | Tetraparesis (HP:0002273) | 2.20365795 |
| 81 | Abnormality of the lumbar spine (HP:0100712) | 2.18667803 |
| 82 | Apathy (HP:0000741) | 2.18407920 |
| 83 | Thin bony cortex (HP:0002753) | 2.16810901 |
| 84 | Osteolytic defects of the hand bones (HP:0009699) | 2.16655535 |
| 85 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.16655535 |
| 86 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.16504065 |
| 87 | Decreased circulating renin level (HP:0003351) | 2.16302691 |
| 88 | Upper motor neuron abnormality (HP:0002127) | 2.13630721 |
| 89 | J-shaped sella turcica (HP:0002680) | 2.12145803 |
| 90 | Poor head control (HP:0002421) | 2.11196771 |
| 91 | Nausea (HP:0002018) | 2.11110760 |
| 92 | Abdominal distention (HP:0003270) | 2.10019325 |
| 93 | Chronic diarrhea (HP:0002028) | 2.07489599 |
| 94 | Premature loss of primary teeth (HP:0006323) | 2.03771871 |
| 95 | Recurrent lower respiratory tract infections (HP:0002783) | 2.03505881 |
| 96 | Asymmetric septal hypertrophy (HP:0001670) | 2.03052057 |
| 97 | Cerebral inclusion bodies (HP:0100314) | 2.01844812 |
| 98 | Distal lower limb muscle weakness (HP:0009053) | 2.01243520 |
| 99 | Inappropriate behavior (HP:0000719) | 1.98626856 |
| 100 | Conjunctival telangiectasia (HP:0000524) | 1.97239393 |
| 101 | Cervical subluxation (HP:0003308) | 1.97033269 |
| 102 | Hemorrhage of the eye (HP:0011885) | 1.95571557 |
| 103 | Meningitis (HP:0001287) | 1.95495957 |
| 104 | Leukocytosis (HP:0001974) | 1.94022290 |
| 105 | Hypergammaglobulinemia (HP:0010702) | 1.93646786 |
| 106 | Cheilitis (HP:0100825) | 1.93173294 |
| 107 | Peripheral demyelination (HP:0011096) | 1.93048752 |
| 108 | Metaphyseal irregularity (HP:0003025) | 1.92986780 |
| 109 | Personality changes (HP:0000751) | 1.91898055 |
| 110 | Pulmonary infiltrates (HP:0002113) | 1.90899493 |
| 111 | Chronic otitis media (HP:0000389) | 1.89370989 |
| 112 | Prolonged neonatal jaundice (HP:0006579) | 1.89198768 |
| 113 | Nephritis (HP:0000123) | 1.88437866 |
| 114 | Gingival bleeding (HP:0000225) | 1.87477238 |
| 115 | Multiple lipomas (HP:0001012) | 1.86798610 |
| 116 | Hyperparathyroidism (HP:0000843) | 1.86410403 |
| 117 | Progressive neurologic deterioration (HP:0002344) | 1.85842650 |
| 118 | Hematochezia (HP:0002573) | 1.85587965 |
| 119 | Increased IgE level (HP:0003212) | 1.84862214 |
| 120 | Intrahepatic cholestasis (HP:0001406) | 1.84523668 |
| 121 | Sepsis (HP:0100806) | 1.84441111 |
| 122 | Abnormality of renin-angiotensin system (HP:0000847) | 1.83919964 |
| 123 | Polyneuropathy (HP:0001271) | 1.83019568 |
| 124 | Increased IgM level (HP:0003496) | 1.81846783 |
| 125 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81796244 |
| 126 | Protuberant abdomen (HP:0001538) | 1.81283001 |
| 127 | Mutism (HP:0002300) | 1.80494431 |
| 128 | Hemoptysis (HP:0002105) | 1.80363403 |
| 129 | Skin nodule (HP:0200036) | 1.80187602 |
| 130 | Arterial thrombosis (HP:0004420) | 1.79441823 |
| 131 | Thoracic kyphosis (HP:0002942) | 1.78684297 |
| 132 | Bone cyst (HP:0012062) | 1.78615737 |
| 133 | Dementia (HP:0000726) | 1.77439442 |
| 134 | Abnormality of chloride homeostasis (HP:0011422) | 1.76460569 |
| 135 | Right ventricular cardiomyopathy (HP:0011663) | 1.76116597 |
| 136 | Progressive visual loss (HP:0000529) | 1.75932890 |
| 137 | Esophageal varix (HP:0002040) | 1.74928566 |
| 138 | Skin ulcer (HP:0200042) | 1.73951470 |
| 139 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.72986170 |
| 140 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.71296765 |
| 141 | Neuronal loss in central nervous system (HP:0002529) | 1.70373762 |
| 142 | Increased serum ferritin (HP:0003281) | 1.69862150 |
| 143 | Albinism (HP:0001022) | 1.68594856 |
| 144 | Joint hemorrhage (HP:0005261) | 1.68067778 |
| 145 | Mucosal telangiectasiae (HP:0100579) | 1.67962235 |
| 146 | Rhinitis (HP:0012384) | 1.67927326 |
| 147 | Abnormality of the pericardium (HP:0001697) | 1.67451050 |
| 148 | Increased CSF protein (HP:0002922) | 1.66737458 |
| 149 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.65235855 |
| 150 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.65235855 |
| 151 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.65046442 |
| 152 | Cardiomegaly (HP:0001640) | 1.64228676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 4.41200613 |
| 2 | RIPK4 | 4.16567466 |
| 3 | BLK | 3.56416163 |
| 4 | MAP3K14 | 3.36809082 |
| 5 | TBK1 | 3.31789184 |
| 6 | MKNK2 | 3.31509952 |
| 7 | EPHA2 | 3.09310909 |
| 8 | NME2 | 2.91673079 |
| 9 | PIM2 | 2.71911548 |
| 10 | ERN1 | 2.70108862 |
| 11 | ACVR1B | 2.54678462 |
| 12 | IRAK3 | 2.53508316 |
| 13 | IRAK4 | 2.50049236 |
| 14 | KIT | 2.41902097 |
| 15 | TYK2 | 2.39208457 |
| 16 | MAP4K1 | 2.00672731 |
| 17 | IKBKE | 1.92879955 |
| 18 | MST1R | 1.92502522 |
| 19 | IKBKB | 1.87876781 |
| 20 | NEK9 | 1.84558316 |
| 21 | MST4 | 1.79041401 |
| 22 | BMX | 1.72988567 |
| 23 | PDK2 | 1.70246734 |
| 24 | LMTK2 | 1.61581346 |
| 25 | MKNK1 | 1.55476165 |
| 26 | PRPF4B | 1.55415670 |
| 27 | TRIB3 | 1.53139224 |
| 28 | JAK3 | 1.52831676 |
| 29 | JAK1 | 1.49327008 |
| 30 | TESK1 | 1.44932780 |
| 31 | CSK | 1.39924962 |
| 32 | RPS6KA4 | 1.31664000 |
| 33 | TRPM7 | 1.29849088 |
| 34 | TAOK3 | 1.28450529 |
| 35 | HCK | 1.26541266 |
| 36 | ZAP70 | 1.24227112 |
| 37 | TXK | 1.23383028 |
| 38 | SYK | 1.19756368 |
| 39 | EPHB1 | 1.18675860 |
| 40 | MAP3K3 | 1.17376609 |
| 41 | FGR | 1.16315739 |
| 42 | MYLK | 1.14587578 |
| 43 | CDC42BPA | 1.11800671 |
| 44 | MAP3K12 | 1.09946601 |
| 45 | EPHB2 | 1.09069563 |
| 46 | MAP3K11 | 1.08543899 |
| 47 | MAPK15 | 1.07810301 |
| 48 | TTN | 1.05794539 |
| 49 | LYN | 1.04870627 |
| 50 | CSF1R | 1.04511403 |
| 51 | STK10 | 1.04189038 |
| 52 | SCYL2 | 1.03496693 |
| 53 | JAK2 | 1.02889656 |
| 54 | MAPKAPK3 | 0.99923308 |
| 55 | MATK | 0.99228637 |
| 56 | CHUK | 0.98513915 |
| 57 | PIM1 | 0.97866524 |
| 58 | MAP2K3 | 0.96549144 |
| 59 | MAP3K13 | 0.96359603 |
| 60 | TGFBR2 | 0.95693357 |
| 61 | LCK | 0.92373618 |
| 62 | RIPK1 | 0.92223078 |
| 63 | PIK3CA | 0.91671347 |
| 64 | TESK2 | 0.88311619 |
| 65 | PKN2 | 0.87340254 |
| 66 | LRRK2 | 0.87115256 |
| 67 | MOS | 0.85838161 |
| 68 | ERBB3 | 0.84775087 |
| 69 | MARK3 | 0.83798138 |
| 70 | BTK | 0.81200061 |
| 71 | SIK1 | 0.79972971 |
| 72 | MAP3K5 | 0.77327111 |
| 73 | PDGFRA | 0.76570527 |
| 74 | STK4 | 0.76099790 |
| 75 | PTK6 | 0.73991448 |
| 76 | CDK6 | 0.70811688 |
| 77 | PRKCD | 0.70770902 |
| 78 | EGFR | 0.70662161 |
| 79 | FGFR3 | 0.68814687 |
| 80 | TEC | 0.68683622 |
| 81 | FES | 0.63708615 |
| 82 | PRKG2 | 0.62512427 |
| 83 | EPHA3 | 0.62380027 |
| 84 | DAPK3 | 0.61335583 |
| 85 | * ABL1 | 0.58871700 |
| 86 | ITK | 0.57173680 |
| 87 | ARAF | 0.56796319 |
| 88 | MAP3K1 | 0.56238105 |
| 89 | GRK7 | 0.54926763 |
| 90 | PAK4 | 0.54254640 |
| 91 | MAP2K2 | 0.53176689 |
| 92 | STK3 | 0.51016866 |
| 93 | MAPKAPK2 | 0.50422766 |
| 94 | YES1 | 0.50067465 |
| 95 | TAOK2 | 0.49785304 |
| 96 | PTK2 | 0.48816082 |
| 97 | BMPR2 | 0.48765550 |
| 98 | MAP2K6 | 0.48607640 |
| 99 | DDR2 | 0.47575577 |
| 100 | KSR2 | 0.47028266 |
| 101 | MAP3K2 | 0.46804356 |
| 102 | TAOK1 | 0.43520778 |
| 103 | PDK1 | 0.43199722 |
| 104 | SMG1 | 0.43056209 |
| 105 | * ABL2 | 0.42813274 |
| 106 | PDPK1 | 0.42157314 |
| 107 | DYRK1B | 0.41992809 |
| 108 | FER | 0.41582764 |
| 109 | SIK3 | 0.41277591 |
| 110 | FGFR4 | 0.40431223 |
| 111 | RPS6KA2 | 0.39665899 |
| 112 | ERBB4 | 0.39072256 |
| 113 | ICK | 0.37486952 |
| 114 | GRK6 | 0.37140865 |
| 115 | FYN | 0.36924310 |
| 116 | DMPK | 0.36175177 |
| 117 | PDGFRB | 0.35423120 |
| 118 | MAP3K10 | 0.34606323 |
| 119 | MAP3K6 | 0.33540606 |
| 120 | MAP3K8 | 0.33523204 |
| 121 | MET | 0.33306270 |
| 122 | STK24 | 0.32970571 |
| 123 | SRC | 0.32373906 |
| 124 | LIMK1 | 0.32065261 |
| 125 | CAMK2G | 0.31719306 |
| 126 | PRKCQ | 0.31209787 |
| 127 | EIF2AK2 | 0.30932636 |
| 128 | GSK3A | 0.25836903 |
| 129 | ADRBK2 | 0.25314838 |
| 130 | NEK6 | 0.23483598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.22429785 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.05555855 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.63540762 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.55225280 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.48795469 |
| 6 | Tuberculosis_Homo sapiens_hsa05152 | 2.47594454 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.43378778 |
| 8 | Phagosome_Homo sapiens_hsa04145 | 2.41307206 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.37475834 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.23160122 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.22510556 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.22299094 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.18763737 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.07393808 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.06782352 |
| 16 | Salmonella infection_Homo sapiens_hsa05132 | 1.95903716 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.95616370 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.91839335 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.87042542 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.70104968 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.69329842 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.67894437 |
| 23 | Allograft rejection_Homo sapiens_hsa05330 | 1.65425519 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.62046075 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.61010007 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.59884832 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.59478375 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.54830819 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.52889217 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52449433 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50623389 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.48340117 |
| 33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.48028516 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.47453744 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.47069390 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.46291427 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.46141618 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.43959346 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43946275 |
| 40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41830988 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40327937 |
| 42 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.34394645 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.33669240 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.32405109 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27795011 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.25308340 |
| 47 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21300176 |
| 48 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.20578921 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19176245 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16746903 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15960144 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11828742 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10994497 |
| 54 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.10217798 |
| 55 | Mineral absorption_Homo sapiens_hsa04978 | 1.06483601 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03076825 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 1.03040040 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01456351 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99670285 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.97571570 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97193597 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.97091320 |
| 63 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96548303 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95910008 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.94674201 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.93926085 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93153041 |
| 68 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.92528861 |
| 69 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.92201755 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89762151 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88367259 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88075218 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85015784 |
| 74 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83798906 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82168053 |
| 76 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80299738 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79992528 |
| 78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.76671041 |
| 79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74316162 |
| 80 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.73790155 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.72779164 |
| 82 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72006389 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71961843 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71630867 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.70452172 |
| 86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69256472 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.68999673 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68732363 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67184229 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66376876 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65558247 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65038160 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64294425 |
| 94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63739780 |
| 95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63595790 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62472011 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.60993991 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.59994334 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59403972 |
| 100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.59129054 |
| 101 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.59037570 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57250814 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.57151674 |
| 104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56904149 |
| 105 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.56809543 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.56199275 |
| 107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53451827 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53344618 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.53111585 |
| 110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50466140 |
| 111 | Bile secretion_Homo sapiens_hsa04976 | 0.50356750 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47963274 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47128216 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46879027 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42596572 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.40561246 |
| 117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39370964 |
| 118 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37661229 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36427257 |
| 120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.35683278 |
| 121 | Adherens junction_Homo sapiens_hsa04520 | 0.31420278 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.30717678 |
| 123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28208042 |
| 124 | Focal adhesion_Homo sapiens_hsa04510 | 0.28121854 |
| 125 | Histidine metabolism_Homo sapiens_hsa00340 | 0.27830458 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27715628 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25553677 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.23752681 |
| 129 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.21852572 |
| 130 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.18258491 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | 0.17960369 |
| 132 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.17235442 |

